Cor Vasa 2015, 57(6):e453-e461 | DOI: 10.1016/j.crvasa.2015.09.009

Imaging in coronary artery disease. Cardiac magnetic resonance.

Mateusz Śpiewak
Magnetic Resonance Unit, Department of Radiology, Institute of Cardiology, Warsaw, Poland

Imaging in coronary artery disease should be regarded as a tool supporting patients' management. Imaging helps physicians to diagnose patients more precisely and to treat them more effectively. There is a constant need to improve the decision-making process in patients with coronary artery disease. The growing number of cardiac magnetic resonance (CMR) centers, patients undergoing CMR studies and the plethora of evidence for the use of CMR both in patients with stable coronary artery disease, as well as acute coronary syndromes, justify reviewing its capabilities. Although research applications and technical developments are of particular value for progress being made in the field of imaging, clinical applications are the most crucial for patients and treating physicians, thus they will be discussed.

Keywords: Acute coronary syndromes; Cardiac magnetic resonance imaging; Coronary artery disease

Received: August 11, 2015; Revised: September 28, 2015; Accepted: September 29, 2015; Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Śpiewak M. Imaging in coronary artery disease. Cardiac magnetic resonance. Cor Vasa. 2015;57(6):e453-461. doi: 10.1016/j.crvasa.2015.09.009.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. G. Montalescot, U. Sechtem, S. Achenbach, et al., 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, European Heart Journal 34 (2013) 2949-3003. Go to original source...
    2. S. Windecker, P. Kolh, F. Alfonso, et al., 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Journal 35 (2014) 2541-2619. Go to original source...
    3. C.W. Hamm, J.P. Bassand, S. Agewall, et al., ESC Committee for Practice Guidelines, ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), European Heart Journal 32 (2011) 2999-3054.
    4. P.G. Steg, S.K. James, D. Atar, et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, European Heart Journal 33 (2012) 2569-2619. Go to original source... Go to PubMed...
    5. O. Bruder, A. Wagner, M. Lombardi, et al., European Cardiovascular Magnetic Resonance (EuroCMR) registry - multi national results from 57 centers in 15 countries, Journal of Cardiovascular Magnetic Resonance 15 (2013) 9. Go to original source... Go to PubMed...
    6. J. Schwitter, M. Lombardi, S. Plein, Coronary artery disease: ischemia-perfusion, in: J. Schwitter (Ed.), CMR Update, J. Schwitter, Lausanne, Switzerland, 2012, 54-73.
    7. E. Nagel, O. Bruder, Coronary artery disease: ischemia-stress dobutamine-CMR, in: J. Schwitter (Ed.), CMR Update, J. Schwitter, Lausanne, Switzerland, 2012, 74-83.
    8. C.M. Kramer, J. Barkhausen, S.D. Flamm, et al., Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols, Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update, Journal of Cardiovascular Magnetic Resonance 15 (2013) 91. Go to original source... Go to PubMed...
    9. L.J. Shaw, D.S. Berman, M.H. Picard, et al., National Institutes of Health/National Heart, Lung, and Blood Institute-Sponsored ISCHEMIA Trial Investigators, Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging, JACC: Cardiovascular Imaging 7 (2014) 593-604. Go to original source... Go to PubMed...
    10. S.T. Hussain, M. Paul, S. Plein, et al., Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease, Journal of Cardiovascular Magnetic Resonance 14 (2012) 65. Go to original source... Go to PubMed...
    11. J.J. McMurray, S. Adamopoulos, S.D. Anker, et al., ESC Committee for Practice Guidelines, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, European Heart Journal 33 (2012) 1787-1847.
    12. R.O. Bonow, G. Maurer, K.L. Lee, et al., Myocardial viability and survival in ischemic left ventricular dysfunction, New England Journal of Medicine 364 (2011) 1617-1625. Go to original source... Go to PubMed...
    13. P. Chareonthaitawee, B.J. Gersh, J.A. Panza, Is viability imaging still relevant in 2012? JACC: Cardiovascular Imaging 5 (2012) 550-558. Go to original source... Go to PubMed...
    14. R.J. Kim, E. Wu, A. Rafael, et al., The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, New England Journal of Medicine 343 (2000) 1445-1453. Go to original source... Go to PubMed...
    15. A. Wagner, H. Mahrholdt, T.A. Holly, et al., Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study, Lancet 361 (2003) 374-379. Go to original source... Go to PubMed...
    16. F.W. Mohr, M.C. Morice, A.P. Kappetein, et al., Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial, Lancet 381 (2013) 629-638. Go to original source... Go to PubMed...
    17. J. Schulz-Menger, D.A. Bluemke, J. Bremerich, et al., Standardized image interpretation and post processing in cardiovascular magnetic resonance, Journal of Cardiovascular Magnetic Resonance 15 (2013) 35. Go to original source... Go to PubMed...
    18. A. Codreanu, W. Djaballah, M. Angioi, et al., Detection of myocarditis by contrast-enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis, Journal of Magnetic Resonance Imaging 25 (2007) 957-964. Go to original source... Go to PubMed...
    19. R.G. Assomull, J.C. Lyne, N. Keenan, et al., The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries, European Heart Journal 28 (2007) 1242-1249. Go to original source... Go to PubMed...
    20. R.C. Cury, K. Shash, J.T. Nagurney, et al., Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department, Circulation 118 (2008) 837-844. Go to original source... Go to PubMed...
    21. R.J. Kim, A. Farzaneh-Far, The diagnostic utility of cardiovascular magnetic resonance in patients with chest pain, elevated cardiac enzymes and non-obstructed coronary arteries, Revista Espanola de Cardiologia 62 (2009) 966-971. Go to original source... Go to PubMed...
    22. H.W. Kim, A. Farzaneh-Far, R.J. Kim, Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications, Journal of the American College of Cardiology 55 (2009) 1-16. Go to original source... Go to PubMed...
    23. D.M. Larson, K.M. Menssen, S.W. Sharkey, et al., "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction, Journal of the American Medical Association 298 (2007) 2754-2760. Go to original source... Go to PubMed...
    24. T. Kubo, T. Imanishi, S. Takarada, et al., Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy, Journal of the American College of Cardiology 50 (2007) 933-939. Go to original source... Go to PubMed...
    25. R.A. Kerensky, M. Wade, P. Deedwania, et al., Veterans Affairs Non-Q-Wave Infarction Stategies in-Hospital (VANQWISH) Trial Investigators, Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory, Journal of the American College of Cardiology 39 (2002) 1456-1463. Go to original source... Go to PubMed...
    26. L. Wang, G. Parodi, A. Maehara, et al., Variable underlying morphology of culprit plaques associated with ST-elevation myocardial infarction: an optical coherence tomography analysis from the SMART trial, European Heart Journal - Cardiovascular Imaging (2015), http://dx.doi.org/10.1093/ehjci/jev105. Go to original source... Go to PubMed...
    27. T. Lockie, E. Nagel, S. Redwood, S. Plein, Use of cardiovascular magnetic resonance imaging in acute coronary syndromes, Circulation 119 (2009) 1671-1681. Go to original source... Go to PubMed...
    28. K.C. Wu, CMR of microvascular obstruction and hemorrhage in myocardial infarction, Journal of Cardiovascular Magnetic Resonance 14 (2012), 68. Go to original source... Go to PubMed...
    29. G. Galasso, S. Schiekofer, C. D'Anna, et al., No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives, Angiology 65 (2014) 180-189. Go to original source... Go to PubMed...
    30. L.A. Malek, M. Klopotowski, M. Spiewak, et al., Platelet reactivity and intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction, Clinical and Applied Thrombosis/Hemostasis 20 (2014) 553-558. Go to original source... Go to PubMed...
    31. E.B. Schelbert, L.Y. Hsu, S.A. Anderson, et al., Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart, Circulation: Cardiovascular Imaging 3 (2010) 743-752. Go to original source... Go to PubMed...
    32. A. Schmidt, C.F. Azevedo, A. Cheng, et al., Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction, Circulation 115 (2007) 2006-2014. Go to original source... Go to PubMed...
    33. A.T. Yan, A.J. Shayne, K.A. Brown, et al., Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality, Circulation 114 (2006) 32-39. Go to original source... Go to PubMed...
    34. R. Delewi, R. Nijveldt, A.M. Van Der Laan, et al., Left ventricular thrombus following primary percutaneous coronary intervention as assessed by cardiac magnetic resonance imaging in acute myocardial infarction, European Heart Journal 31 (Abstract Supplement) (2010) 774.
    35. R. Delewi, F. Zijlstra, J.J. Piek, Left ventricular thrombus formation after acute myocardial infarction, Heart 98 (2012) 1743-1749. Go to original source... Go to PubMed...
    36. N. Garg, J.C. Lopez-Mattei, H. Ibrahim, et al., Sub-optimal detection of left ventricular thrombi with 2D transthoracic echocardiography compared to cardiac magnetic resonance despite the use of contrast echocardiography, Circulation 126 (2012) A13052.
    37. R. Luechinger, J. Schwitter, O. Bruder, Safety of MRI, in: J. Schwitter (Ed.), CMR Update, J. Schwitter, Lausanne, Switzerland, 2012, 30-52. Go to original source...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes